• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子β1(TGF-β1)产生不足会使人类卵巢癌细胞系中的自分泌生长抑制回路失活。

Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.

作者信息

Zeinoun Z, Teugels E, De Bleser P J, Neyns B, Geerts A, De Greve J

机构信息

Department of Medical Oncology and Hematology, Academisch Ziekenhuis, Vrije Universiteit Brussel, Brussels, Belgium.

出版信息

Anticancer Res. 1999 Jan-Feb;19(1A):413-20.

PMID:10226576
Abstract

TGF-beta 1 is a secreted polypeptide that elicits an antiproliferanve response in many cell types. However, many epithelial cancer cell lines are resistant to TGF-beta 1 growth inhibition. We investigated the in vitro growth suppressive effect of TGF-beta 1 on five ovarian cancer cell lines. Two of these (OVCAR-3 and AZ364) were growth inhibited by TGF-beta 1. The other three cell lines (SKOV-3, AZ224 and AZ547), were resistant to the antiproliferative action of the cytokine. All five cell lines produce TGF-beta 1 mRNA at very different levels and also secrete the TGF-beta 1 polypeptide, but mainly in a biologically latent form as tested by ELISA; this probably explains the fact that the TGF-beta 1 autocrine growth inhibition circuit is not active, even in sensitive cell lines. Even complete activation of the in vitro secreted latent form would be insufficient to induce growth arrest when compared to the levels of exogenous TGF-beta 1 needed to induce growth arrest in sensitive cell lines. The TGF-beta 1 receptor type I mRNA is expressed by all five ovarian cancer cell lines, but two of them (AZ224 and AZ547) lack detectable TGF-beta 1 receptor type II mRNA expression. Since TGF-beta 1 signaling requires both receptor types, the lack of receptor type II in two cell lines may explain their resistance to growth inhibition. Further experiments should be carried out on receptors and downstream components to pinpoint the cause of resistance in the SKOV cell line.

摘要

转化生长因子β1(TGF-β1)是一种分泌型多肽,可在多种细胞类型中引发抗增殖反应。然而,许多上皮癌细胞系对TGF-β1的生长抑制具有抗性。我们研究了TGF-β1对五种卵巢癌细胞系的体外生长抑制作用。其中两种细胞系(OVCAR-3和AZ364)受到TGF-β1的生长抑制。另外三种细胞系(SKOV-3、AZ224和AZ547)对该细胞因子的抗增殖作用具有抗性。所有五种细胞系均以非常不同的水平产生TGF-β1 mRNA,并且也分泌TGF-β1多肽,但通过酶联免疫吸附测定(ELISA)检测主要以生物学潜伏形式存在;这可能解释了即使在敏感细胞系中,TGF-β1自分泌生长抑制回路也不活跃这一事实。与在敏感细胞系中诱导生长停滞所需的外源性TGF-β1水平相比,即使完全激活体外分泌的潜伏形式也不足以诱导生长停滞。所有五种卵巢癌细胞系均表达I型TGF-β1受体mRNA,但其中两种细胞系(AZ224和AZ547)缺乏可检测到的II型TGF-β1受体mRNA表达。由于TGF-β1信号传导需要两种受体类型,两种细胞系中缺乏II型受体可能解释了它们对生长抑制的抗性。应针对受体和下游成分进行进一步实验,以查明SKOV细胞系中的抗性原因。

相似文献

1
Insufficient TGF-beta 1 production inactivates the autocrine growth suppressive circuit in human ovarian cancer cell lines.转化生长因子β1(TGF-β1)产生不足会使人类卵巢癌细胞系中的自分泌生长抑制回路失活。
Anticancer Res. 1999 Jan-Feb;19(1A):413-20.
2
Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.雄激素对卵巢癌细胞中转化生长因子β受体的下调作用。
Cancer Res. 2000 Feb 15;60(4):929-35.
3
Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.III型转化生长因子(TGF)β受体功能异常的细胞对自分泌和外源性TGF-β1的反应差异
Cell Growth Differ. 1999 Jan;10(1):11-8.
4
Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).转化生长因子-β1信号通路参与1,25(OH)₂D₃诱导的Caco-2细胞生长抑制过程。
Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G864-74. doi: 10.1152/ajpgi.00524.2001.
5
Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.人类癌细胞系中的转化生长因子-β受体:转录本、蛋白质及增殖分析
Anticancer Res. 1997 May-Jun;17(3C):1849-60.
6
Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.转化生长因子β受体在人胰腺腺癌中的差异表达
Anticancer Res. 2000 Jan-Feb;20(1A):43-51.
7
Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.骨软骨肉瘤中转化生长因子-β 亚型及受体的表达
Virchows Arch. 2002 May;440(5):491-7. doi: 10.1007/s00428-001-0544-2. Epub 2001 Oct 20.
8
The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.在人前列腺癌细胞系LNCaP中,转化生长因子-β1(TGF-β1)信号传导并不需要传统的I型转化生长因子-β(TGF-β)受体。
Exp Cell Res. 1998 May 25;241(1):151-60. doi: 10.1006/excr.1998.4034.
9
The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.转化生长因子-β受体在人类动脉粥样硬化中的表达:因受体失衡导致细胞凋亡获得性抵抗的证据。
J Mol Cell Cardiol. 1999 Sep;31(9):1627-42. doi: 10.1006/jmcc.1999.0999.
10
Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.转化生长因子β信号传导在人类子宫内膜癌发生早期即被破坏,同时伴随着生长抑制的丧失。
Cancer Res. 2002 May 15;62(10):2778-90.

引用本文的文献

1
Overexpression of TMEM158 contributes to ovarian carcinogenesis.跨膜蛋白158(TMEM158)的过表达促进卵巢癌发生。
J Exp Clin Cancer Res. 2015 Aug 4;34(1):75. doi: 10.1186/s13046-015-0193-y.
2
Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition.前列腺凋亡反应蛋白 4 介导转化生长因子-β诱导的上皮间质转化。
Cell Death Dis. 2014 Feb 6;5(2):e1044. doi: 10.1038/cddis.2014.7.